ZURA (STOCKS)
Zura Bio Limited Class A Ordinary Shares
$5.680000
+0.030000 (+0.53%)
Prev close: $5.650000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Sandeep C. Kulkarni
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $538.92M
- Employees
- 30
- P/E (TTM)
- -4.74
- P/B (TTM)
- 4.10
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $6.60M |
| Operating Expenses | $75.25M |
| Research and Development | $42.08M |
| Other Operating Expenses | $33.16M |
| Operating Income/Loss | -$75.25M |
| Income/Loss From Continuing Operations After Tax | -$68.65M |
| Income/Loss From Continuing Operations Before Tax | -$68.65M |
| Net Income/Loss | -$68.65M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$68.65M |
| Net Income/Loss Available To Common Stockholders, Basic | -$99.35M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $30.70M |
| Preferred Stock Dividends And Other Adjustments | $30.70M |
| Basic Earnings Per Share | -$1.06 |
| Diluted Earnings Per Share | -$1.06 |
| Basic Average Shares | 94,160,138 |
| Diluted Average Shares | 94,160,138 |
| Assets | $113.95M |
| Current Assets | $112.31M |
| Noncurrent Assets | $1.64M |
| Fixed Assets | $126.00K |
| Other Non-current Assets | $1.51M |
| Liabilities | $12.41M |
| Current Liabilities | $12.41M |
| Accounts Payable | $1.28M |
| Other Current Liabilities | $11.13M |
| Noncurrent Liabilities | $0.00 |
| Equity | $101.54M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $101.54M |
| Liabilities And Equity | $113.95M |
| Net Cash Flow From Operating Activities | -$64.82M |
| Net Cash Flow From Operating Activities, Continuing | -$64.82M |
| Net Cash Flow From Investing Activities | -$113.00K |
| Net Cash Flow From Investing Activities, Continuing | -$113.00K |
| Net Cash Flow From Financing Activities | -$2.16M |
| Net Cash Flow From Financing Activities, Continuing | -$2.16M |
| Net Cash Flow | -$67.09M |
| Net Cash Flow, Continuing | -$67.09M |
| Comprehensive Income/Loss | -$68.65M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$68.65M |
| Other Comprehensive Income/Loss | $0.00 |